Reveal ctDNA

FusionPlex

Immunoverse

VariantPlex

Archer in the News

  • Archer presents at Molecular Med TRI-CON 2017
    Jan 17, 2017

    Join us at Molecular Med TRI-CON 2017 in San Francisco this February. This conference focuses on Molecular Medicine, specifically on Discovery, Genomics, Diagnostics and Information Technology. Our featured talk will be Improving NGS-Based Liquid Biopsy Mutation Detection with Anchored Multiplex PCR presented by Archer CSO, General Manager, Josh Stahl.


  • Archer exhibits at USCAP 2017 Annual Meeting
    Jan 17, 2017

    Meet us in San Antonia, TX this March for The USCAP 2017 Annual Meeting. This conference boasts the largest gathering of Pathologists in the world. We will be presenting posters illustrating our latest technologies including detection of mutations in ctDNA and B- and T-cell immune repertoire characterization with Anchored Multiplex PCR and Next-Generation Sequencing.


  • More News


Archer kits find genetic mutations with NGS

Archer's proprietary target-enrichment chemistry and software work together to provide highly confident mutation calls.

For Research Use Only. Not for use in diagnostic procedures.For Research Use Only. Not for use in diagnostic procedures.


Fusions

Gene Fusions and Translocations

Gene fusions can occur as a result of chromosomal inversions, interstitial deletions, or translocations in the genome. Gene fusions can drive cancer development and progression, making them important therapeutic targets. Archer technology is purpose-built for accurate, powerful and scalable gene fusion detection with next generation sequencing.

Detected in the following assays:

Archer FusionPlex
RNA assays
CNVs

Copy Number Variations (CNVs)

Copy number variation (CNV) is a common form of structural genomic aberration in which large regions of the genome are deleted or duplicated. Constitutional and somatic CNVs are associated with a wide variety of cancers and represent an important area of research. Archer technology enables highly-multiplexed, quantitative assessment of genomic regions through next generation sequencing.

Detected in the following assays:

Archer VariantPlex
DNA assays
Indels

Insertions/Deletions (indels)

Insertions and deletions (indels) are mutations of the genome resulting from the omission or addition of nucleotides into a sequence of DNA. Indels can alter amino acid coding sequence and cause detrimental cellular effects. Archer technology is uniquely suited for indel detection due to novel chemistry and powerful next generation sequencing analysis.

SNVs/SNPs

Single Nucleotide Variants/Polymorphisms (SNVs, SNPs)

Point mutations, single nucleotide variants (SNV) or single base substitutions of the genome can have various implications on cellular function and can cause or lead to diseases of the genome – like cancer. Archer technology enables the precise targeting of the genome for nucleotide-level detection of point mutations with next generation sequencing.

Expression

RNA Gene Expression

Gene expression is a measure of functional RNA that can provide critical insights into cellular origin and regulation. The molecular signatures gathered from RNA abundance can assist in classification of tumor types. The quantitative nature of Archer technology allows for measuring relative RNA abundance so researchers can get more information from next generation sequencing.

Detected in the following assays:

Archer FusionPlex
RNA assays

How to contact us

Address

2477 55th Street, Suite 202

Boulder, CO 80301

Phone

Phone: (877) 771 1093

Phone: (303) 357 9001

All content © 2017 ArcherDX, Inc.

For Research Use Only. Not for use in diagnostic procedures. For Research Use Only. Not for use in diagnostic procedures.